1-2 of 2
Aldo Serafini, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II study of 90 y Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Marginal Zone Lymphoma

Jesus C Fabregas, MD, James E. Hoffman, MD, Tulay Koru-Sengul, PhD, Miao Feng, Deborah Goodman, Aldo Serafini, MD, Peter J Hosein, MD, Alexandra Stefanovic, MD, Joseph D. Rosenblatt, MD, Izidore S. Lossos, MD
Journal: Blood
Blood (2014) 124 (21): 1762.
https://doi.org/10.1182/blood.V124.21.1762.1762
Published: 2014
Journal Articles

High Incidence of False Positive PET Scans in Patients with Aggressive Non-Hodgkins Lymphoma Treated with Rituximab-Containing Regimens.

Hyo S. Han, MD, Maricer P. Escalon, MD, Aldo Serafini, MD, Izidore S. Lossos, MD
Journal: Blood
Blood (2006) 108 (11): 2401.
https://doi.org/10.1182/blood.V108.11.2401.2401
Published: 2006